درباره این اپیزود
When designing a trial for cutaneous lupus erythematosus (CLE), consider earlier primary endpoints, limited background therapy, and balanced racial representation to address placebo response. That’s just a few of the insights from the first-ever systematic review of placebo response in CLE trials, shared here by Dr. Stéphanie Légaré, first author of Placebo Response in Randomised Controlled Trials of Systemic Therapies for Cutaneous Lupus Erythematosus: A Systematic Review and Meta-Analysis.
Want more on placebo response in rheumatology trials? Learn from leading KOLs Drs. Andreas Kerschbaumer and Joan Merrill at a free educational breakfast event happening during ACR Convergence 2026. Register here: https://go.inderocro.com/podcast/description/episode-43/acr-bf-registration.
Want more on placebo response in rheumatology trials? Learn from leading KOLs Drs. Andreas Kerschbaumer and Joan Merrill at a free educational breakfast event happening during ACR Convergence 2026. Register here: https://go.inderocro.com/podcast/description/episode-43/acr-bf-registration.
انگلیسی
ایالات متحده آمریکا
رونوشت 🔗
Are you the producer of this podcast?
Add a podcast transcript
Need Audio-to-Text?
Transcribe with Listen411 in Just 60 Seconds
جستجوی اپیزودهای گذشته
اپیزودهای قبلی Phase Forward را جستجو کن.
قسمت های دیگر در این پادکست
In this episode, Sarah Ballard, Agency Director at KDM, dives into the strategic power of PR in navigating the complex world of scientific and clinical communications. With over 20 years in B2B marketing, Sarah reveals how public relations drives trust and credibility amid digital disruption and st…
In this episode of Phase Forward, Hubert Godziatkowski, founder of the Polish Atopic Disease Association (PTCA), shares how patient organizations can reshape clinical trials. With over 800,000 people in Poland affected by atopic dermatitis, PTCA is working to improve clarity in consent forms, promo…
In this episode of Phase Forward, Dr. Ana Palijan explores how early phase clinical trials have evolved beyond their traditional safety focus. With over 25 years in translational research, she discusses the growing complexity driven by scientific advances, technology integration, and global trial e…
In the Season 3 finale of Phase Forward, clinical research veterans Ted Trafford and Brad Hightower share essential insights on building stronger collaborations between sponsors, CROs, and clinical trial sites. Drawing from decades of hands-on experience, they explore how sustained site motivation,…
In this episode, Isabel Dorion, Senior Director of Clinical Operations at Indero, shares expert insights on the critical role of Clinical Research Associates (CRAs) in ensuring trial quality and patient safety. Explore key strategies for effective CRA oversight and discover how quality reviews and …
سلب مسئولیت: پادکست و آثار هنری تعبیه شده در این صفحه متعلق به Phase Forward است که متعلق به صاحب آن است و به Listen Notes، Inc وابسته یا تایید نشده است.
ویرایش
از کمک شما برای بروز نگهداشتن پایگاهدادههای پادکست سپاسگزاریم
